ArticleArchives of virology2025
Purification and serological detection of maize yellow mosaic virus.
Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Maize yellow mosaic virus (MaYMV) is an emerging polerovirus that was first reported in maize in China in 2013 but has since been reported in Africa and the Americas. Due to its novelty, no antibodies or serological diagnostics for the virus existed prior to the current study. In this study, we developed the first purification method for maize yellow mosaic virus with the goal of generating an antibody and subsequently developing diagnostic tests. Yields of 0.634-1.275 milligrams of virus per kilogram of maize tissue were obtained, which is comparable to the yields obtained for other grass-infecting poleroviruses. Under an electron microscope, purified virus particles appear icosahedral in shape and roughly 30 nm in diameter. A polyclonal antibody was generated against the gradient-purified virus preparation and cross-adsorbed to uninfected maize tissue. The antibody is effective for detection of MaYMV via enzyme-linked immunosorbent assay (ELISA) and western blot. The ELISA could detect virus in quantities as low as 0.395 µg and in 1:32 dilutions of infected plant extract, and the antibody showed little to no cross-reactivity with five closely related viruses. After protein gel electrophoresis and antibody detection, protein bands corresponding in size to two viral structural proteins could be seen: the coat protein of roughly 21 kDa and the readthrough protein, around 72 kDa. Finally, virus particles purified using this protocol were found to be transmissible by the primary aphid vector, Rhopalosiphum maidis, and to cause systemic, symptomatic infection of maize plants, indicating that the vector transmissibility and infectivity of the virus particles were preserved during purification.
Indexed as
Identifiers
40085313What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.